LYT-200
Lyt-200 is a humanized monoclonal antibody targeting Galectin-9. Lyt-200 exhibits potent inhibitory effects on hematological cancer cells and can also be used in combination with methotrexate (HY-14519) for research purposes[1].
Product Specifications
UNSPSC
12352203
Target
Galectin
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.16
Smiles
[LYT-200]
Molecular Weight
(145.46 kDa)
References & Citations
[1]Curtis J Henry, et al. Lyt-200, a Humanized Anti-Galectin-9 Antibody, Exhibits Preclinical Efficacy in Models of Hematological Malignancies. Blood. 2022 November 15,140 (Supplement 1) : 8837.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
